JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boc, S. F.
Right arrow Articles by Landino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boc, S. F.
Right arrow Articles by Landino, T.
Journal of the American Podiatric Medical Association Volume 91 Number 7 365-368 2001
Copyright © 2001 American Podiatric Medical Association

Acute Charcot Foot Changes versus Osteomyelitis

Does Tc-99m HMPAO Labeled Leukocytes Scan Differentiate?

Steven F. Boc, DPM*, Keith Brazzo, DPM{dagger}, Dana Lavian, DPM{dagger} and Thomas Landino, PT{ddagger}

* Fellow, American College of Foot and Ankle Surgeons; Associate Dean for Academic Affairs and Chairman/Associate Professor Department of Surgery, Temple University School of Podiatric Medicine, Philadelphia, PA; Director, St Agnes Medical Center Podiatric Surgical Residency Program, Philadelphia, PA. Mailing address: Temple University School of Podiatric Medicine, Eighth at Race St, Philadelphia, PA 19107.
{dagger} Submitted during second-year residency, St Agnes Medical Center Podiatric Surgical Residency Program, Philadelphia, PA.
{ddagger} Submitted during fourth year, Temple University School of Podiatric Medicine, Philadelphia, PA.

Abstract

Osteomyelitis often complicates a diabetic neuropathic foot, leading to amputation, decreased function, and quality of life. Therefore, early detection and treatment are paramount. Furthermore, neuroarthropathic (Charcot) changes in the foot often resemble infection and must be differentiated. Currently, the Tc-99m HMPAO Labeled Leukocytes Scan is considered to be the most reliable noninvasive imaging modality of choice in determining Charcot foot changes versus osteomyelitis. The purpose of this article is to alert the clinician that although the Tc-99m HMPAO Labeled Leukocytes Scan may be the second most reliable test next to bone biopsy for determining osteomyelitis, false positives do occur. (J Am Podiatr Med Assoc 91(7): 365-368, 2001)




This article has been cited by other articles:


Home page
 J. Am. Podiatr. Med. Assoc.Home page
M. S. Judge
Infection and Neuroarthropathy: The Utility of C-reactive Protein as a Screening Tool in the Charcot Foot
J Am Podiatr Med Assoc, January 1, 2008; 98(1): 1 - 6.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Podiatric Medical Association.